In the intensely crowded environment of living cells, proteins have difficulty folding into their proper structures and in maintaining these structures in face of the normal wear and tear of their existence. Misfolded proteins are responsible for some of the most devastating diseases of mankind. But the folding problem is as old as life itself. Not surprisingly, the mechanisms that cells use to cope with it (proteins chaperones, remodeling factors, osmolytes, and sophisticated degradation machineries) are universally employed and highly conserved. Moreover, it now appears that the same types of misfolded states that can be terribly toxic in some circumstances can be beneficial in others. This allows us to use tractable model organisms to study deeply complex protein folding problems that are of interest to human biology and medicine. This application aims to take advantage of yeast cells, and proteins derived from them, to investigate a particularly important type of fold, the self-templating amyloids, and the protein chaperones and remodeling factors that govern their conformational states. We will focus on two such proteins from the yeast Saccharomyces cerevisiae, Sup35, Rnq1, and one from Aplysia californica, CPEB. Using an array of biochemical and genetic methods in our own laboratory, and collaborating with others who have biophysical expertise far beyond our own, we will a) determine the basic structural framework of amyloids formed by the three proteins, b) investigate the effects of chaperones and synthetic compounds on prion nucleation and propagation in vivo and in vitro, and c) examine why some amyloidogenic conformers are toxic and others are not. Relevance: Amyloids are responsible for some of the most devastating diseases of mankind, including Alzheimers, Parkinsons, and Huntingtins Diseases. Yet we still have little understanding of the nature of the toxic species, much less a clear route to therapeutic intervention. Yeast amyloids undergo remarkably similar conformational conversions and are much more amenable to investigation, offering the hope of more rapid progress on the very difficult problems of amyloid structure, conformational change, and the nature of toxic states.
| Kayatekin, Can; Amasino, Audra; Gaglia, Giorgio et al. (2018) Translocon Declogger Ste24 Protects against IAPP Oligomer-Induced Proteotoxicity. Cell 173:62-73.e9 |
| Frederick, Kendra K; Michaelis, Vladimir K; Caporini, Marc A et al. (2017) Combining DNP NMR with segmental and specific labeling to study a yeast prion protein strain that is not parallel in-register. Proc Natl Acad Sci U S A 114:3642-3647 |
| Frederick, Kendra K; Michaelis, Vladimir K; Corzilius, Björn et al. (2015) Sensitivity-enhanced NMR reveals alterations in protein structure by cellular milieus. Cell 163:620-8 |
| Reymer, Anna; Frederick, Kendra K; Rocha, Sandra et al. (2014) Orientation of aromatic residues in amyloid cores: structural insights into prion fiber diversity. Proc Natl Acad Sci U S A 111:17158-63 |
| Frederick, Kendra K; Debelouchina, Galia T; Kayatekin, Can et al. (2014) Distinct prion strains are defined by amyloid core structure and chaperone binding site dynamics. Chem Biol 21:295-305 |
| Kayatekin, Can; Matlack, Kent E S; Hesse, William R et al. (2014) Prion-like proteins sequester and suppress the toxicity of huntingtin exon 1. Proc Natl Acad Sci U S A 111:12085-90 |
| Lancaster, Alex K; Nutter-Upham, Andrew; Lindquist, Susan et al. (2014) PLAAC: a web and command-line application to identify proteins with prion-like amino acid composition. Bioinformatics 30:2501-2 |
| Halfmann, Randal; Wright, Jessica R; Alberti, Simon et al. (2012) Prion formation by a yeast GLFG nucleoporin. Prion 6:391-9 |
| Bryan Jr, Allen W; O'Donnell, Charles W; Menke, Matthew et al. (2012) STITCHER: Dynamic assembly of likely amyloid and prion ?-structures from secondary structure predictions. Proteins 80:410-20 |
| Krishnan, Rajaraman; Goodman, Jessica L; Mukhopadhyay, Samrat et al. (2012) Conserved features of intermediates in amyloid assembly determine their benign or toxic states. Proc Natl Acad Sci U S A 109:11172-7 |
Showing the most recent 10 out of 61 publications
